{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:50:29Z","timestamp":1761760229562,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bavarian Nordic Berna GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Cases of confirmed tick-borne encephalitis (TBE) have increased dramatically over the last 30 years, highlighting growing endemicity across Eurasia. Two preventative vaccines, Encepur\u00ae (Bavarian Nordic A\/S, Hellerup, Denmark) and FSME-Immun\u00ae (Pfizer Ireland Pharmaceuticals, Cork, Ireland), are licensed in Europe. For both vaccines, primary immunisation consists of a three-dose regimen, administered over approximately one year using \u201cConventional\u201d dosing schedules. Both vaccines can also be administered using \u201cRapid\u201d schedules, which shorten the interval between the first two doses but still take around a year to complete. Currently, only Encepur offers an approved \u201cExpress\u201d schedule, whereby all three priming doses are given within 21 days. The effectiveness of TBE vaccination is markedly higher in individuals who receive \u22653 doses, compared with those who receive only one or two doses, indicating the importance of series completion. Moreover, seropositivity takes several weeks to develop after vaccination. As such, individuals are advised to initiate vaccination before peak tick season to allow sufficient time to develop protective immunity during periods of highest risk. Despite these considerations, vaccine uptake and series completion remain suboptimal in TBE-endemic regions. Furthermore, many vaccinees\u2014including travellers with limited time before departure and residents of endemic areas\u2014do not initiate vaccination until peak tick season, when risk is greatest. Broader use of Encepur\u2019s Express schedule may help to address these challenges. The Express schedule\u2019s 21-day timeframe may help to increase series completion by reducing drop-offs associated with prolonged dosing intervals. Additionally, it can support timely protection by enabling series completion, with sufficient time post-vaccination to develop protective immunity, all within a single-risk season, even among late initiators. In this narrative review, we evaluate the safety and immunogenicity of Encepur\u2019s Express schedule and discuss its potential utility across a broader range of vaccinees. These insights may help inform TBE vaccine recommendations and support efforts towards improving vaccination strategies amid increasing TBE risk.<\/jats:p>","DOI":"10.3390\/v17111439","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:38:22Z","timestamp":1761759502000},"page":"1439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fast-Track to Protection? A Review of Encepur\u2019s Express Dosing Schedule for Tick-Borne Encephalitis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-076X","authenticated-orcid":false,"given":"Kyra","family":"Zens","sequence":"first","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, CH-8001 Zurich, Switzerland"},{"name":"Institute for Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4832-0767","authenticated-orcid":false,"given":"Ralph","family":"Torgler","sequence":"additional","affiliation":[{"name":"Bavarian Nordic Berna GmbH, Oberriedstrasse 68, CH-3174 Thoerishaus, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Horn","sequence":"additional","affiliation":[{"name":"Kinder- und Jugendarztpraxis, Achenweg 1, 83471 Sch\u00f6nau, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3963-3804","authenticated-orcid":false,"given":"Carsten Schade","family":"Larsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus N, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1292\/jvms.18-0373","article-title":"Epidemiology and pathological mechanisms of tick-borne encephalitis","volume":"81","author":"Yoshii","year":"2019","journal-title":"J. Vet. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kunze, M., Banovic, P., Bogovic, P., Briciu, V., Civljak, R., Dobler, G., Hristea, A., Kerlik, J., Kuivanen, S., and Kyncl, J. (2022). Recommendations to improve tick-borne encephalitis surveillance and vaccine uptake in Europe. Microorganisms, 10.","DOI":"10.3390\/microorganisms10071283"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1024\/0040-5930.62.11.719","article-title":"Epidemiology of tick-borne encephalitis (TBE) in Switzerland 1984 to 2004","volume":"62","author":"Zimmermann","year":"2005","journal-title":"Ther. Umsch."},{"key":"ref_4","first-page":"20756","article-title":"Epidemiology of tick-borne encephalitis in Switzerland, 2005 to 2011","volume":"19","author":"Schuler","year":"2014","journal-title":"Surveill. Outbreak Rep."},{"key":"ref_5","unstructured":"European Centre of Disease Prevention and Control (2025, October 01). Factsheet About Tick-Borne Encephalitis (TBE). Available online: https:\/\/www.ecdc.europa.eu\/en\/tick-borne-encephalitis\/facts\/factsheet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"taae153","DOI":"10.1093\/jtm\/taae153","article-title":"Mapping the risk of tick-borne encephalitis in Europe for informed vaccination decisions","volume":"32","author":"Jong","year":"2024","journal-title":"J. Travel Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s11756-022-01097-5","article-title":"New challenges posed by ticks and tick-borne diseases","volume":"77","author":"Sparagano","year":"2022","journal-title":"Biologia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.01.004","article-title":"Tick-borne encephalitis in Europe: A brief update on epidemiology, diagnosis, prevention, and treatment","volume":"62","author":"Riccardi","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"ref_9","unstructured":"Centers for Disease Control and Prevention (2025, September 01). Areas at Risk for Tick-Borne Encephalitis, Available online: https:\/\/www.cdc.gov\/tick-borne-encephalitis\/data-maps\/index.html."},{"key":"ref_10","unstructured":"European Centre of Disease Prevention and Control (2025, September 05). Tick-Borne Encephalitis-Annual Epidemiological Report for 2022. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/tick-borne-encephalitis-annual-epidemiological-report-2022."},{"key":"ref_11","unstructured":"European Centre of Disease Prevention and Control (2025, September 30). Tick-Borne Encephalitis in Europe. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/healthtopics\/vectors\/world-health-day-2014\/Documents\/factsheet-tick-borne-encephalitis.pdf#:~:text=Approximately%205000-12%20000%20cases%20of%20TBE,are%20reported%20in%20Europe%20each%20year."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2300221","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300221","article-title":"Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019","volume":"29","author":"Albinsson","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Brechet, A., Kohler, P., Dorr, T., Grassli, F., Vock, M., Salat, J., Ruzek, D., Friedl, A., Vuichard-Gysin, D., and Croxatto, A. (2025). Tick-borne encephalitis virus seroprevalence and infection incidence in Switzerland, 2020\u20132021. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-92560-1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4161\/hv.29984","article-title":"Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: Systematic review and meta-analysis","volume":"10","author":"Domnich","year":"2014","journal-title":"Hum. Vaccine Immunother."},{"key":"ref_15","unstructured":"European Medicines Agency (2025, October 01). List of Nationally Authorised Medicinal Products, Active Substance: Tick-Borne Encephalitis Vaccine (Inactivated). Available online: https:\/\/www.ema.europa.eu\/en\/documents\/psusa\/tick-borne-encephalitis-vaccine-inactivated-list-nationally-authorised-medicinal-products-psusa\/00002951\/201701_en.pdf."},{"key":"ref_16","unstructured":"Bavarian Nordic (2025, September 07). Summary of Product Characteristics. Encepur Children. Available online: https:\/\/docetp.mpa.se\/LMF\/Encepur%20Barn%20%20%20Suspension%20for%20injection%20ENG%20SmPC_09001bee8294355c.pdf."},{"key":"ref_17","unstructured":"Bavarian Nordic (2025, September 07). Summary of Product Characteristics. Encepur., Available online: https:\/\/docetp.mpa.se\/LMF\/Encepur%20%20%20Suspension%20for%20injection%20ENG%20SmPC_09001bee82943560.pdf."},{"key":"ref_18","unstructured":"Pfizer Limited (2025, October 01). TicoVac SmPC. Available online: https:\/\/www.medicines.org.uk\/emc\/product\/1923\/smpc#about-medicine."},{"key":"ref_19","unstructured":"Pfizer Limited (2025, October 01). TicoVac Junior SmPC. Available online: https:\/\/www.medicines.org.uk\/emc\/product\/1927\/smpc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101876","DOI":"10.1016\/j.tmaid.2020.101876","article-title":"Immunogenicity and safety of the tick-borne encephalitis vaccination (2009\u20132019): A systematic review","volume":"37","author":"Rampa","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.vaccine.2021.12.028","article-title":"Effectiveness of TBE vaccination in southern Germany and Latvia","volume":"40","author":"Erber","year":"2022","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nygren, T.M., Pilic, A., B\u00f6hmer, M.M., Wagner-Wiening, C., Wichmann, O., Harder, T., and Hellenbrand, W. (2022). Tick-borne encephalitis vaccine effectiveness and barriers to vaccination in Germany. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-15447-5"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e061228","DOI":"10.1136\/bmjopen-2022-061228","article-title":"Retrospective, matched case-control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006\u20132020","volume":"12","author":"Zens","year":"2022","journal-title":"BMJ Open"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Miazga, W., Wnuk, K., Tatara, T., Switalski, J., Matera, A., Religioni, U., and Gujski, M. (2023). The long-term efficacy of tick-borne encephalitis vaccines available in Europe\u2014A systematic review. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08562-9"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/INF.0000000000004034","article-title":"Effectiveness of Tick-borne Encephalitis Vaccines in Children, Latvia, 2018\u20132020","volume":"42","author":"Zavadska","year":"2023","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.cmi.2023.06.028","article-title":"Effectiveness of tick-borne encephalitis vaccination in Latvia, 2018\u20132020: An observational study","volume":"29","author":"Zavadska","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Palmborg, A., Angulo, F.J., Zhang, P., Pilz, A., Stark, J., Moisi, J.C., and Jodar, L. (2025). Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-86968-y"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2300558","DOI":"10.2807\/1560-7917.ES.2024.29.18.2300558","article-title":"A combined cross-sectional analysis and case-control study evaluating tick-borne encephalitis vaccination coverage, disease and vaccine effectiveness in children and adolescents, Switzerland, 2005 to 2022","volume":"29","author":"Zens","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cmi.2017.01.012","article-title":"Compliance with vaccination against tick-borne encephalitis virus in Germany","volume":"23","author":"Jacob","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ttbdis.2018.02.007","article-title":"Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study","volume":"9","author":"Erber","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.vaccine.2020.12.047","article-title":"Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany","volume":"39","author":"Schley","year":"2021","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102059","DOI":"10.1016\/j.ttbdis.2022.102059","article-title":"Vaccine uptake in 20 countries in Europe 2020: Focus on tick-borne encephalitis (TBE)","volume":"14","author":"Pilz","year":"2023","journal-title":"Ticks Tick Borne Dis."},{"key":"ref_33","unstructured":"ESCMID Study Group for Tick-Borne Diseases\u2014ESGBOR (2025, September 09). European Tick-Borne Disease Information Resource. Available online: https:\/\/www.esgbor.org\/other-tick-borne-diseases\/tick-borne-encephalitis\/."},{"key":"ref_34","unstructured":"VaccinarS\u00ec (2025, September 15). Tick-Borne Encephalitis Vaccine (TBE). Available online: https:\/\/www.vaccinarsi.eu\/tick-borne-encephalitis-vaccine."},{"key":"ref_35","unstructured":"Patient (2025, September 15). Tick-Borne Encephalitis Vaccine. Available online: https:\/\/patient.info\/travel-and-vaccinations\/travel-vaccinations-leaflet\/tick-borne-encephalitis-immunisation."},{"key":"ref_36","unstructured":"Pfizer Limited (2025, September 18). Highlights of Prescribing Information. TicoVac. Available online: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=15600&format=pdf."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2003.08.005","article-title":"Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0264-410X(96)00081-3","article-title":"Tick-borne encephalitis: Development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study","volume":"14","author":"Girgsdies","year":"1996","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0264-410X(02)00592-3","article-title":"Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.vaccine.2006.10.028","article-title":"Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule","volume":"25","author":"Beran","year":"2007","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/hv.3.2.3747","article-title":"Tick-borne encephalitis (TBE) vaccination in children: Advantage of the rapid immunization schedule (i.e., days 0, 7, 21)","volume":"3","author":"Schoendorf","year":"2007","journal-title":"Hum. Vaccine"},{"key":"ref_42","first-page":"130","article-title":"Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule","volume":"293","author":"Beran","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/j.vaccine.2014.06.028","article-title":"Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety","volume":"32","author":"Beran","year":"2014","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ackermann-Gaumann, R., Lang, P., and Zens, K.D. (2024). Defining the \u201cCorrelate(s) of Protection\u201d to tick-borne encephalitis vaccination and infection\u2014Key points and outstanding questions. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1352720"},{"key":"ref_45","unstructured":"World Health Organization (2025, September 07). Vaccines Against Tick-Borne Encephalitis (TBE). WHO Position Paper 2011, Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/position_paper_documents\/tick-borne-encephalitis\/tbe-grad-safety.pdf?sfvrsn=16ee9a04_2."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"J. Med. Virol."},{"key":"ref_47","unstructured":"Centers for Disease Control and Prevention (2025, September 03). Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Tick-Borne Encephalitis (TBE) Vaccine, Available online: https:\/\/www.cdc.gov\/acip\/grade\/tbe-travel-lab.html?utm_source."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lindblom, P., Wilhelmsson, P., Fryland, L., Matussek, A., Haglund, M., Sjowall, J., Vene, S., Nyman, D., Forsberg, P., and Lindgren, P.E. (2014). Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100860"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.vaccine.2020.11.002","article-title":"Understanding immunosenescence and its impact on vaccination of older adults","volume":"38","author":"Allen","year":"2020","journal-title":"Vaccine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14760584.2017.1358620","article-title":"Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules","volume":"16","author":"Galgani","year":"2017","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_52","unstructured":"Global Health Press (2025, September 05). Extension of the Booster Interval for the TBE Vaccine, Encepur Adult, Germany. Available online: https:\/\/tbenews.com\/tbe\/snapshot-week-25-2025-extension-of-the-booster-interval-for-the-tbe-vaccine-encepur-adult-germany."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.vaccine.2023.04.061","article-title":"Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up","volume":"41","author":"Beran","year":"2023","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2017.12.081","article-title":"Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence","volume":"37","author":"Beran","year":"2019","journal-title":"Vaccine"},{"key":"ref_55","unstructured":"NHS (2025, October 01). Travel Vaccination Advice. Available online: https:\/\/www.nhs.uk\/vaccinations\/travel-vaccinations\/travel-vaccination-advice\/."},{"key":"ref_56","unstructured":"Center for Disease Control (2025, October 03). Traveler\u2019s Health: Before You Travel, Available online: https:\/\/wwwnc.cdc.gov\/travel\/page\/before-travel."},{"key":"ref_57","unstructured":"International Society of Travel Medicine (2025, September 10). Pre-Travel Health Advice Fact Sheet. Available online: https:\/\/www.istm.org\/wp-content\/uploads\/general-travel-health-advice.pdf."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jtm.12139","article-title":"A profile of travelers\u2014An analysis from a large swiss travel clinic","volume":"21","author":"Buhler","year":"2014","journal-title":"J. Travel Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"tav017","DOI":"10.1093\/jtm\/tav017","article-title":"Travellers\u2019 profile, travel patterns and vaccine practices\u2014A 10-year prospective study in a Swiss Travel Clinic","volume":"23","author":"Boubaker","year":"2016","journal-title":"J. Travel Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:46:36Z","timestamp":1761759996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["v17111439"],"URL":"https:\/\/doi.org\/10.3390\/v17111439","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}